New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
07:08 EDTENMDEntreMed submitts application for clinical trials of ENMD-2076 in China
EntreMed announced that it has moved to expand its Phase 2 clinical trial for its drug candidate ENMD-2076 in advanced ovarian clear cell carcinoma, or OCCC, with the submission of a new drug global clinical trial application with China's Food and Drug Administration, or CFDA. The ongoing Phase 2 trial is currently being conducted at Princess Margaret Cancer Centre in Toronto, along with participation from up to seven additional cancer centers in Canada and the U.S.
News For ENMD From The Last 14 Days
Check below for free stories on ENMD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ENMD

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use